NEWS FEED & ADDITIVE MAGAZINE July 2023 81 Vilofoss, a global leader in the premix and animal nutrition sector, shared a new trial that showed good effects for Stalosan F for piglets in the farrowing phase. The trial was performed on a sow farm with 2 300 females, located in the West of Santa Catarina in Brazil. The result of this trial showed that the use of the environmental dry-cleaning concept was able to reduce the incidence of litters with diarrhea, the prevalence of omphalitis and the fall behind the rate in piglets, contributing to greater weight at weaning and homogeneity of the litters. According to the trial, enteric diseases in the farrowing phase are relevant problems due to their economic losses. However, piglet losses (pre-weaning mortality rate) are only part of the economic problem. Future consequences of the non-uniformity of weaned piglets and the gut health of these animals are ignored. Therefore, strategic procedures focused on reducing the infective pressure can be important control tools. Read more>> NaturalShrimp, Inc., a biotechnology aquaculture company that developed and patented the first shrimp-focused commercially operational RAS (Recirculating Aquaculture System), signed a licensing agreement with Niterra Co., Ltd. The agreement allows for the trial use of NaturalShrimp’s patented shrimp growing technologies at an aquaculture farm in Japan. Under the terms of the agreement, NaturalShrimp will provide Niterra access to its proprietary Electrocoagulation (EC) and Hydrogas™ technologies to test the suitability and viability of the patented technology in shrimp cultivation within smallscale, locally owned aquacultural farms. Both companies have recognized that the trial serves as a foundation for potential future collaborations, joint business relationships and ventures, transactions, or other business combinations. The trial period is expected to take up to six (6) months from the deployment of the required equipment at the chosen trial location. This equipment includes Electrocoagulation equipment, Hydrogas and water dosing equipment, assorted connectors and other necessary components. Upon successful completion of this initial trial, Niterra will consider conducting further studies and trials to evaluate the efficacy of NaturalShrimp technologies on additional aquatic species, under separate agreements. “Niterra Ventures Company’s mission to pursue innovative solutions and tackle tomorrow’s challenges makes them an ideal partner for our technologies,” said Gerald Easterling, CEO of NaturalShrimp. “Niterra is the first company in Asia to license our technology, expanding our opportunity to provide fresh, naturally grown shrimp in one of the world’s largest seafood markets. We expect a successful initial trial that will lay the groundwork for additional agreements with different species.“ Read more>> New trial shows effects of Stalosan F for piglets NaturalShrimp signs technology licensing agreement with Niterra
RkJQdWJsaXNoZXIy MTUxNjkxNQ==